UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13129) 13129
Magazine Article (17) 17
Book Chapter (13) 13
Conference Proceeding (13) 13
Dissertation (6) 6
Publication (4) 4
Book / eBook (2) 2
Web Resource (2) 2
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11865) 11865
science & technology (9757) 9757
life sciences & biomedicine (9332) 9332
female (7108) 7108
oncology (6508) 6508
taxoids - administration & dosage (5765) 5765
middle aged (5707) 5707
male (5483) 5483
aged (5158) 5158
antineoplastic combined chemotherapy protocols - therapeutic use (5086) 5086
docetaxel (4702) 4702
adult (4069) 4069
chemotherapy (3666) 3666
biological and medical sciences (3466) 3466
medical sciences (3362) 3362
taxoids - therapeutic use (3328) 3328
breast neoplasms - drug therapy (3146) 3146
treatment outcome (3050) 3050
cancer (2758) 2758
taxoids (2573) 2573
antineoplastic agents (2529) 2529
tumors (2295) 2295
taxoids - adverse effects (2101) 2101
pharmacology. drug treatments (2069) 2069
antineoplastic agents - therapeutic use (2018) 2018
antineoplastic combined chemotherapy protocols - adverse effects (1948) 1948
animals (1919) 1919
paclitaxel - analogs & derivatives (1915) 1915
breast cancer (1811) 1811
taxoids - pharmacology (1799) 1799
breast neoplasms - pathology (1733) 1733
pharmacology & pharmacy (1683) 1683
lung neoplasms - drug therapy (1679) 1679
cisplatin - administration & dosage (1564) 1564
neoplasm staging (1560) 1560
cell line, tumor (1523) 1523
paclitaxel - administration & dosage (1512) 1512
disease-free survival (1474) 1474
aged, 80 and over (1431) 1431
drug administration schedule (1421) 1421
care and treatment (1378) 1378
carcinoma, non-small-cell lung - drug therapy (1354) 1354
deoxycytidine - analogs & derivatives (1256) 1256
prostatic neoplasms - drug therapy (1243) 1243
antineoplastic agents - administration & dosage (1195) 1195
prostate cancer (1184) 1184
fluorouracil - administration & dosage (1164) 1164
mice (1163) 1163
medicine & public health (1133) 1133
antineoplastic combined chemotherapy protocols - administration & dosage (1121) 1121
prognosis (1108) 1108
antineoplastic agents - pharmacology (1107) 1107
survival rate (1106) 1106
retrospective studies (1094) 1094
research (1067) 1067
antineoplastic agents, phytogenic - therapeutic use (1065) 1065
analysis (1010) 1010
survival analysis (1008) 1008
neoplasm metastasis (999) 999
deoxycytidine - administration & dosage (980) 980
drug resistance, neoplasm (978) 978
dose-response relationship, drug (954) 954
paclitaxel - therapeutic use (954) 954
chemotherapy, adjuvant (949) 949
metastasis (939) 939
gynecology. andrology. obstetrics (897) 897
antimitotic agents (885) 885
antineoplastic agents - adverse effects (845) 845
neoadjuvant therapy (838) 838
paclitaxel (834) 834
taxoids - chemistry (823) 823
combined modality therapy (817) 817
lung neoplasms - pathology (808) 808
hematology, oncology and palliative medicine (793) 793
drug therapy (777) 777
paclitaxel - adverse effects (746) 746
adenocarcinoma - drug therapy (731) 731
antineoplastic agents, phytogenic - administration & dosage (728) 728
prostatic neoplasms - pathology (687) 687
disease progression (667) 667
taxoids - pharmacokinetics (656) 656
stomach neoplasms - drug therapy (655) 655
neoplasms - drug therapy (654) 654
follow-up studies (643) 643
apoptosis - drug effects (641) 641
carcinoma, non-small-cell lung - pathology (624) 624
cyclophosphamide - administration & dosage (620) 620
health aspects (604) 604
carboplatin - administration & dosage (601) 601
doxorubicin - administration & dosage (598) 598
clinical trials (597) 597
paclitaxel - pharmacology (597) 597
antineoplastic agents, phytogenic - adverse effects (593) 593
carcinoma, squamous cell - drug therapy (588) 588
kaplan-meier estimate (586) 586
mammary gland diseases (584) 584
time factors (584) 584
cancer research (583) 583
chemistry (583) 583
prospective studies (564) 564
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12259) 12259
Japanese (687) 687
Chinese (237) 237
French (170) 170
German (126) 126
Russian (65) 65
Italian (39) 39
Spanish (36) 36
Hungarian (20) 20
Portuguese (11) 11
Polish (9) 9
Dutch (8) 8
Korean (6) 6
Czech (5) 5
Danish (4) 4
Lithuanian (4) 4
Finnish (2) 2
Hebrew (2) 2
Turkish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Croatian (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 387, Issue 10027, pp. 1540 - 1550
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Cell survival | Medical treatment | FDA approval | Health care facilities | Survival | Patients | Evidence-based medicine | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers | Index Medicus | Abridged Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 34, Issue 1, pp. 251 - 261
Journal Article
Nano letters, ISSN 1530-6984, 01/2017, Volume 17, Issue 1, pp. 242 - 248
Journal Article
Journal Article